ATE250408T1 - Clindamycin enthaltendes intravaginalzäpfchen - Google Patents

Clindamycin enthaltendes intravaginalzäpfchen

Info

Publication number
ATE250408T1
ATE250408T1 AT00948739T AT00948739T ATE250408T1 AT E250408 T1 ATE250408 T1 AT E250408T1 AT 00948739 T AT00948739 T AT 00948739T AT 00948739 T AT00948739 T AT 00948739T AT E250408 T1 ATE250408 T1 AT E250408T1
Authority
AT
Austria
Prior art keywords
suppository containing
containing clindamycin
intravaginal suppository
intravaginal
clindamycin
Prior art date
Application number
AT00948739T
Other languages
English (en)
Inventor
Lorraine E Pena
Phil B Bowman
Robert S Chao
Carolyn V Pesheck
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE250408T1 publication Critical patent/ATE250408T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00948739T 1999-08-06 2000-07-20 Clindamycin enthaltendes intravaginalzäpfchen ATE250408T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14756199P 1999-08-06 1999-08-06
PCT/US2000/019533 WO2001010407A1 (en) 1999-08-06 2000-07-20 Intravaginal clindamycin ovule composition

Publications (1)

Publication Number Publication Date
ATE250408T1 true ATE250408T1 (de) 2003-10-15

Family

ID=22522061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948739T ATE250408T1 (de) 1999-08-06 2000-07-20 Clindamycin enthaltendes intravaginalzäpfchen

Country Status (23)

Country Link
US (2) US6495157B1 (de)
EP (1) EP1200065B1 (de)
JP (1) JP2003519095A (de)
KR (1) KR100670085B1 (de)
CN (1) CN1160056C (de)
AR (1) AR025045A1 (de)
AT (1) ATE250408T1 (de)
AU (1) AU768907B2 (de)
CA (1) CA2378572A1 (de)
DE (1) DE60005524T2 (de)
DK (1) DK1200065T3 (de)
ES (1) ES2207532T3 (de)
HN (1) HN2000000166A (de)
MA (1) MA26749A1 (de)
MX (1) MXPA02001320A (de)
NZ (1) NZ517039A (de)
PA (1) PA8499101A1 (de)
PE (1) PE20010484A1 (de)
PT (1) PT1200065E (de)
SI (1) SI1200065T1 (de)
SV (1) SV2001000138A (de)
TW (1) TWI232111B (de)
WO (1) WO2001010407A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2004014338A1 (en) * 2002-02-05 2004-02-19 Pharmacia & Upjohn Company Composition and method for rectal delivery of a lincosamide antibacterial drug
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (de) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023184A2 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2005027807A1 (en) * 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060078616A1 (en) * 2004-08-30 2006-04-13 Georgewill Dawaye A Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
CA2605341A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
CN100446774C (zh) * 2005-05-31 2008-12-31 黑龙江龙桂制药有限公司 盐酸克林霉素阴道泡腾片及其制备方法
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
WO2007079389A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
EP1968544A2 (de) * 2006-01-05 2008-09-17 Drugtech Corporation Arzneimittel-verabreichungssystem zur bioadhäsion an einer vulvovaginalen oberfläche
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
DE102009055644A1 (de) * 2009-11-25 2011-06-01 Nicole Nedela Dildo-Set
CN103735491B (zh) * 2013-12-31 2016-01-13 哈尔滨欧替药业有限公司 克林霉素磷酸酯阴道膨胀栓及其制备方法和检测方法
US10751299B2 (en) * 2018-09-04 2020-08-25 Babak Ghalili Cannabinoid and menthol compositions and methods
US10813963B2 (en) 2018-09-04 2020-10-27 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
WO2021177938A1 (en) * 2020-03-02 2021-09-10 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
MX2020011523A (es) * 2020-10-29 2022-05-02 Exeltis Pharma Mexico S A De C V Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812683B2 (ja) * 1988-07-26 1998-10-22 富士製薬工業株式会社 持続性を有するモルヒネ直腸投与製剤
JPH05213752A (ja) * 1992-02-06 1993-08-24 Fujisawa Asutora Kk 坐 剤
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition

Also Published As

Publication number Publication date
NZ517039A (en) 2003-01-31
JP2003519095A (ja) 2003-06-17
MA26749A1 (fr) 2004-12-20
AR025045A1 (es) 2002-11-06
MXPA02001320A (es) 2004-09-10
TWI232111B (en) 2005-05-11
KR20020038713A (ko) 2002-05-23
US20020197320A1 (en) 2002-12-26
PA8499101A1 (es) 2001-12-14
WO2001010407A1 (en) 2001-02-15
ES2207532T3 (es) 2004-06-01
AU768907B2 (en) 2004-01-08
DK1200065T3 (da) 2004-02-02
AU6219800A (en) 2001-03-05
PE20010484A1 (es) 2001-04-20
DE60005524D1 (de) 2003-10-30
SI1200065T1 (en) 2004-04-30
EP1200065A1 (de) 2002-05-02
KR100670085B1 (ko) 2007-01-17
PT1200065E (pt) 2004-02-27
EP1200065B1 (de) 2003-09-24
HK1047538A1 (en) 2003-02-28
CA2378572A1 (en) 2001-02-15
US6495157B1 (en) 2002-12-17
DE60005524T2 (de) 2004-08-05
CN1360495A (zh) 2002-07-24
SV2001000138A (es) 2001-10-24
HN2000000166A (es) 2001-04-20
CN1160056C (zh) 2004-08-04

Similar Documents

Publication Publication Date Title
ATE250408T1 (de) Clindamycin enthaltendes intravaginalzäpfchen
DE60012154D1 (de) Zange
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
DE60023998D1 (de) Immunoassay
EE200100502A (et) Ühendid
NO990113D0 (no) Flerskrog-fart°y
NO992430D0 (no) R°rkobling
NO992198D0 (no) R°rledningspigg
DE60026411D1 (de) Wippschalter
DE50113706D1 (de) Träger
NO990431D0 (no) Golfk°llehode
FI20000543L (fi) Siirtojärjestely
DE69922587D1 (de) Übertragungsverfahren
DE50007279D1 (de) Flachschlüssel
DE60044218D1 (de) em
FI19992517L (fi) Syömäpuikot
DE60008886D1 (de) Tastenanordnung
DK1050518T3 (da) Silikatmasse
NO20013769L (no) Kalsilytiske forbindelser
ID27526A (id) Turunan ii kuinolin-4-il
DE50006616D1 (de) Zange
NO20020466D0 (no) Kalsilytiske forbindelser
DE50009430D1 (de) Abgaskrümmer
DE60016860D1 (de) Folientastatur
EP1132096A4 (de) Suppositorien

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200065

Country of ref document: EP